0000000001258382

AUTHOR

Girolamo Teresi

showing 15 related works from this author

Polyaspartamide-g-Polylactide graft cpolymers able to form nanoparticles obtained by a novel synthetic strategy.

2009

GRAFT COPOLYMERS POLYMERIC NANOPARTICLES POLY(LACTIC ACID)Settore CHIM/09 - Farmaceutico Tecnologico Applicativo
researchProduct

SISTEMI NANOSTRUTTURATI POLIMERICI PER LA VEICOLAZIONE ED IL RILASCIO DI FARMACI

2011

FARMACISettore CHIM/09 - Farmaceutico Tecnologico ApplicativoNANOSTRUTTURATIPOLIMERICI
researchProduct

NANOTECHNOLOGIES FOR BIOMEDICAL APLICATIONS

2010

DRUG DELIVERY SYSTEMS POLYAMINOACIDS NANOMEDICINESettore CHIM/09 - Farmaceutico Tecnologico Applicativo
researchProduct

POLYMERIC MICELLES BASED ON A PHOSPHOLIPID/ POLYASPARTAMIDIC COPOLYMER FOR BECLOMETHASONE DIPROPIONATE DELIVERY TO THE LUNGS

2010

Settore CHIM/09 - Farmaceutico Tecnologico Applicativoalphabeta-poly(N-2-hydroxyethyl)-DL-aspartamide (PHEA) 12-Distearoyl-sn-glycero-3-Phosphoethanolamine-N-[Amino(Polyethylene glycol)2000] (DSPE-PEG2000-NH2) polymeric micelles drug delivery beclomethasone dipropionate (BDP) pulmonary diseases.
researchProduct

NOVEL COMPOSED GALACTOSYLATED NANODEVICES CONTAINING A RIBAVIRIN PRODRUG AS HEPATIC CELL-TARGETED CARRIERS FOR HCV TREATMENT

2013

In this paper, we describe the preparation of liver-targeted nanoparticles potentially able to carry to hepatocytes a ribavirin (RBV) prodrug, exploiting the presence of carbohydrate receptors in the liver (i.e., ASGPR in hepatocytes). These particles were obtained starting from a galactosylated phospholipid-polyaminoacid conjugate. This latter was obtained by chemical reaction of ALPHA, BETA -poly(N-2-hydroxyethyl) (2-aminoethylcarbamate)-DL-aspartamide (PHEA-EDA) with 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(succinyl) sodium salt (DPPE), and subsequent reaction with lactose, obtaining PHEA-EDA-DPPE-GAL copolymer. To enhance the entrapment into obtained nanostructures, a hydroph…

Biomedical EngineeringPharmaceutical ScienceMedicine (miscellaneous)NanoparticleBioengineeringAntiviral AgentsDiffusionNon-competitive inhibitionNanocapsulesMaterials TestingRibavirinHumansGeneral Materials ScienceProdrugschemistry.chemical_classificationGalactoseHep G2 CellsProdrugCarbohydrateVirologyCombinatorial chemistryHepatitis CIn vitroGalactosylated Nanoparticles Hepatic Cell-Targeted Carriers Active Targeting Ribavirin Tripalmitate Hepatitis C.EnzymechemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryConjugate
researchProduct

NANOPARTICLES BASED ON NOVEL AMPHIPHILIC POLYASPARTAMIDE COPOLYMERS

2010

In this article, the synthesis of two amphiphilic polyaspartamide copolymers, useful to obtain polymeric nanoparticles without using surfactants or stabilizing agents, is described. These copolymers were obtained starting from α,β-poly-(N-2-hydroxyethyl)-dl-aspartamide (PHEA) by following a novel synthetic strategy. In particular, PHEA and its pegylated derivative (PHEA-PEG2000) were functionalized with poly(lactic acid) (PLA) through 1,1′-carbonyldiimidazole (CDI) activation to obtain PHEA–PLA and PHEA-PEG2000–PLA graft copolymers, respectively. These copolymers were properly purified and characterized by 1H-NMR, FT-IR, and Size Exclusion Chromatography (SEC) analyses, which confirmed that…

Materials scienceALPHABETA-poly-(N-2-hydroxyethyl)-DL-aspartamide (PHEA) poly(lactic acid) (PLA) poly(ethylene glycol) (PEG) graft copolymers nanoparticlesSize-exclusion chromatographytechnology industry and agricultureNanoparticleBioengineeringGeneral Chemistrymacromolecular substancesCondensed Matter PhysicsAtomic and Molecular Physics and Opticschemistry.chemical_compoundX-ray photoelectron spectroscopychemistrystomatognathic systemSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoModeling and SimulationAmphiphilePolymer chemistryPEG ratioCopolymerZeta potentialGeneral Materials ScienceDerivatization
researchProduct

Biocompatible polymeric micelles with polysorbate 80 for use in brain targeting.

2008

In this paper, the synthesis and characterization of novel amphiphilic graft copolymers based on an alpha,beta-poly(N-2-hydroxyethyl)-D, L-aspartamide (PHEA) backbone and D, L-polylactic acid (PLA) hydrophobic side chains are reported. These copolymers were obtained starting from PHEA-ethylenediamine (PHEA-EDA), which was functionalized with polysorbate 80 (PS(80)) and/or PLA in order to obtain the PHEA-EDA-PS(80)-PLA and PHEA-EDA-PLA samples, respectively. The degrees of derivatization, DD(PS80) and DD(PLA), of PHEA-EDA-PS80-PLA, calculated by (1)H-NMR, resulted in being 1.2 +/- 0.03 mol% and 0.54 +/- 0.05 mol%, respectively, while that of PHEA-EDA-PLA was found to be 0.60 +/- 0.05 mol%. S…

chemistry.chemical_classificationChromatographyMaterials scienceMechanical EngineeringSize-exclusion chromatographyBioengineeringGeneral ChemistryPolymerMicelleAMPHIPHILIC COPOLYMERS MICELLES BRAIN TARGETING POLYSORBATE 80chemistry.chemical_compoundchemistryMechanics of MaterialsSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoAmphiphileSide chainZeta potentialCopolymerGeneral Materials ScienceElectrical and Electronic EngineeringDerivatizationNuclear chemistryNanotechnology
researchProduct

Phospholipid-polyaspartamide micelles for pulmonary delivery of corticosteroids

2011

A novel drug delivery system for beclomethasone dipropionate (BDP) has been constructed through self-assembly of a pegylated phospholipid-polyaminoacid conjugate. This copolymer was obtained by chemical reaction of α,β-poly(N-2-hydroxyethyl)-DL-aspartamide (PHEA) with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethyleneglycol)2000] (DSPE-PEG(2000)-NH(2)). Benefiting from the amphiphilic structure with the hydrophilic shell based on both PHEA and PEG and many hydrophobic stearoyl tails, PHEA-PEG(2000)-DSPE copolymer was able to self assemble into micelles in aqueous media above a concentration of 1.23 × 10(-7)M, determined by fluorescence studies. During the self-assembling …

ErythrocytesBiocompatibilityCell SurvivalDrug CompoundingDrug StorageALPHABETA-Poly(N-2-hydroxyethyl)-dl- aspartamide (PHEA) 12-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethyleneglycol)2000](DSPE-PEG2000-NH2) Polymeric micelles Drug delivery Beclomethasone dipropionate (BDP) Pulmonary diseasesPhospholipidPharmaceutical Science[object Object]HemolysisMicelleCell LinePolyethylene Glycolschemistry.chemical_compoundDrug StabilityAmphiphilePEG ratioPulmonary diseasesHumans?Beclomethasone dipropionate (BDP)Particle SizeLungMicellesDrug CarriersChromatographyAqueous solutionMolecular StructureChemistryPhosphatidylethanolaminesBeclomethasonetechnology industry and agriculture?-Poly(N-2-hydroxyethyl)-dl-aspartamide (PHEA)Spectrometry FluorescenceSolubilitySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryDrug deliveryPolymeric micellesNanocarriersPeptidesHydrophobic and Hydrophilic InteractionsNuclear chemistry
researchProduct

QoS-aware SIP User Agent Operation in QoS-supporting networks

2006

researchProduct

NANOPARTICELLE POLIMERICHE OTTENUTE DA NUOVI COPOLIMERI DI UNA POLIASPARTAMIDE

2009

Settore CHIM/09 - Farmaceutico Tecnologico Applicativonanoparticelle polimeriche poliaspartamide
researchProduct

NEW PEGYLATED POLYHYDROXYETHYLASPARTAMIDE-SPERMINE COPOLYMER AS GENE DELIVERY SYSTEM

2009

GENE DELIVERY polyhydroxyethylaspartamideSettore CHIM/09 - Farmaceutico Tecnologico Applicativo
researchProduct

PREPARATION AND CHARACTERIZATION OF GALACTOSILATED NANODEVICES CONTAINING A RIBAVIRIN PRODRUG FOR LIVER TARGETING.

2012

Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoNANOPARTICLESRIBAVIRIN PRODRUGLIVER TARGETING
researchProduct

The Developing of a SIP User Agent

2006

researchProduct

Novel galactosylated nanoparticles containing a ribavirin prodrug as hepatic cell-targeted carriers for hcv treatment

2012

Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoRIBAVIRIN PRODRUGLIVER TARGETINGPOLYMERIC NANOPARTICLES
researchProduct

Nanodevices based on a novel galactosaminated phospholipid-polyaspartamide for liver targeting of a ribavirin prodrug

2011

LIVER TARGETING GRAFT COPOLYMERS POLIASPARTAMIDESettore CHIM/09 - Farmaceutico Tecnologico Applicativo
researchProduct